| [1] |
Lai HS, Chen WJ, Chen CC, et al. Long-term prognosis and factors affecting biliary atresia from experience over a 25 year period[J]. Chang Gung Med J, 2006, 29(3): 234-239.
|
| [2] |
Bijl EJ, Bharwani KD, Houwen RH, et al. The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review[J]. Neth J Med, 2013, 71(4): 170-173.
|
| [3] |
Lee S, Park H, Moon SB, et al. Long-term results of biliary atresia in the era of liver transplantation[J]. Pediatr Surg Int, 2013, 29(12): 1297-1301.
|
| [4] |
Tiao MM, Yang CY, Tsai SS, et al. Liver transplantation for biliary atresia in Taiwan: a national study[J]. Transplant Proc, 2008, 40(10): 3569-3570.
|
| [5] |
Seda Neto J, Feier FH, Bierrenbach AL, et al. Impact of Kasai portoenterostomy on liver transplantation outcomes: a retrospective cohort study of 347 children with biliary atresia[J]. Liver Transpl, 2015, DOI: 10.1002/lt.24132[Epub ahead of print]. |
| [6] |
Wang Q, Yan L, Zhang M, et al. Can primary LDLT be the alternative first line treatment for infant patients with biliary atresia?[J]. Hepatogastroenterology, 2013, 60(124): 807-812.
|
| [7] |
Ogawa E, Hori T, Doi H, et al. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience[J]. Clin Transplant, 2014, 28(9): 1031-1040.
|
| [8] |
Poupon R. Evidence-based treatment of primary biliary cirrhosis[J]. Dig Dis, 2014, 32(5):626-630.
|
| [9] |
Reichen J. Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis[J]. ACP J Club, 2008, 148(1): 17.
|
| [10] |
Milkiewicz P. Liver transplantation in primary biliary cirrhosis[J]. Clin Liver Dis, 2008, 12(2): 461-472.
|
| [11] |
Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence[J]. Clin Res Hepatol Gastroenterol, 2011, 35(6/7):446-454.
|
| [12] |
European Association for the Study of the Liver. Easl clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267.
|
| [13] |
Lammers WJ, van Buuren HR, Hirschfield GM, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study[J]. Gastroenterology, 2014, 147(6): 1338-1349, e5.
|
| [14] |
Silveira MG, Talwalkar JA, Lindor KD, et al. Recurrent primary biliary cirrhosis after liver transplantation[J]. Am J Transplant, 2010, 10(4): 720-726.
|
| [15] |
Montano-Loza AJ, Wasilenko S, Bintner J, et al. Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation[J]. Am J Transplant, 2010, 10(4): 852-858.
|
| [16] |
Pandanaboyana S, Bell R, Bartlett AJ, et al. Meta-analysis of duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis[J]. Transpl Int, 2015, 28(4):485-491.
|
| [17] |
Venkat VL, Ranganathan S, Mazariegos GV, et al. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients[J]. Liver Transpl, 2014, 20(6): 679-686.
|
| [18] |
Gelley F, Zádori G, Görög D, et al. Recurrence of primary sclerosing cholangitis after liver transplantation: the Hungarian experience[J]. Interv Med Appl Sci, 2014, 6(1): 16-18.
|
| [19] |
Maithel SK, Gamblin TC, Kamel I, et al. Multidisciplinary approaches to intrahepatic cholangiocarcinoma[J]. Cancer, 2013, 119(22): 3929-3942.
|
| [20] |
Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma[J]. Surgery, 2013, 153(6): 811-818.
|
| [21] |
Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? a review of 17 years of experience in a tertiary institution[J]. Surgery, 2015, 157(4): 666-675.
|
| [22] |
Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?[J]. Am J Transplant, 2014, 14(3): 660-667.
|
| [23] |
Hashimoto K, Miller CM. Liver transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2015, 22(2):138-143.
|
| [24] |
DeOliveira ML. Liver transplantation for cholangiocarcinoma: current best practice[J]. Curr Opin Organ Transplant, 2014, 19(3): 245-252.
|
| [25] |
Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers[J]. Gastroenterology, 2012, 143(1): 88-98, e3.
|
| [26] |
Duignan S, Maguire D, Ravichand CS, et al. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience[J]. HPB, 2014, 16(1):91-98.
|
| [27] |
Welling TH, Feng M, Wan S, et al. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma[J]. Liver Transpl, 2014, 20(1): 81-88.
|
| [28] |
Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma[J]. Curr Opin Gastroenterol, 2012, 28(3):244-252.
|
| [29] |
Chen ZY, Yan LN, Zeng Y, et al. Preliminary experience with indications for liver transplantation for hepatolithiasis[J]. Transplant Proc, 2008, 40(10): 3517-3522.
|
| [30] |
Zahmatkeshan M, Bahador A, Geramizade B, et al. Liver transplantation for caroli disease[J]. Int J Organ Transplant Med, 2012, 3(4): 189-191.
|
| [31] |
Harring TR, Nguyen NT, Liu H, et al. Caroli disease patients have excellent survival after liver transplant[J]. J Surg Res, 2012, 177(2): 365-372.
|
| [32] |
Mabrut JY, Kianmanesh R, Nuzzo G, et al. Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery multicenter study[J]. Ann Surg, 2013, 258(5): 713-721.
|